Julie Person
Chief Administrative Officer en THIRD HARMONIC BIO, INC. .
Fortuna: - $ al 31/03/2024
Perfil
Julie Person is currently the Chief Administrative Officer at Third Harmonic Bio, Inc. She previously worked as the Vice President-Human Resources at Sangamo Therapeutics, Inc. from 2019 to 2020.
She also held the position of Head-Human Resources at Astellas Gene Therapies, Inc. Additionally, Julie served as the Chief People Officer at Neumora Therapeutics, Inc. from 2021 to 2022.
Prior to that, she was the VP-Talent Management & Organizational Development at Shire Plc from 2017 to 2019.
Ms. Person completed her undergraduate degree at St. Mary's College of California.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
THIRD HARMONIC BIO, INC.
-.--% | 04/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Julie Person
| Empresas | Cargo | Inicio |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Chief Administrative Officer | 01/06/2022 |
Antiguos cargos conocidos de Julie Person.
| Empresas | Cargo | Fin |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Human Resources Officer | 01/06/2022 |
| SANGAMO THERAPEUTICS, INC. | Human Resources Officer | 01/04/2020 |
| SHIRE | Human Resources Officer | 01/03/2019 |
| AUDENTES THERAPEUTICS, INC. | Human Resources Officer | - |
Formación de Julie Person.
| St. Mary's College of California | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| THIRD HARMONIC BIO, INC. | Health Technology |
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Julie Person
